Cho, A K; Melega, W P; Kuczenski, R et al. (2001) Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39:161-6
|
Shilling, P D; Kelsoe, J R; Kuczenski, R et al. (2000) Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis. Neuroscience 96:83-90
|
Kuczenski, R; Segal, D S (1999) Sensitization of amphetamine-induced stereotyped behaviors during the acute response. J Pharmacol Exp Ther 288:699-709
|
Segal, D S; Kuczenski, R (1999) Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses. Psychopharmacology (Berl) 142:182-92
|
Segal, D S; Kuczenski, R (1999) Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile. J Pharmacol Exp Ther 291:19-30
|
Kuczenski, R; Segal, D S (1999) Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate. Psychopharmacology (Berl) 147:96-103
|
Kuczenski, R; Segal, D S (1999) Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors. Brain Res 822:164-74
|
Cho, A K; Melega, W P; Kuczenski, R et al. (1999) Caudate-putamen dopamine and stereotypy response profiles after intravenous and subcutaneous amphetamine. Synapse 31:125-33
|
Kuczenski, R; Segal, D S; Todd, P K (1997) Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology (Berl) 134:221-9
|
Kuczenski, R; Segal, D S (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68:2032-7
|
Showing the most recent 10 out of 38 publications